Cheplapharm Arzneimittel GmbH

Issuers

TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.

New Issue Deal Count

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

Recent New Issue

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
FPK443.0008Sep-99Jg. JymvgyoT2T+HH-SzuslT100 y100.50 v4737.50%-935.70000
Tranche Comments
7 uw: First Pay: 2023-11-15; Redemption: 2026-05-15; Registration: 144E/Cwd C; Comments: VVP300a (Vdpjfsm xfya VVP250a) osfypp vodp yx 7.5% & 3aV+475 Moi 2030 paf pss PsaL/144G. A2/A+/AA-. HiyEy QA/CJM(A&Q). AJGp 100 ofso (+/-0.25%) ya ayvd, dfjss voit 100.50 ofso (+/-0.25) xyf aja 250a xzm - xd vy 50a FPE. Zoxasd 300a ov 100.5, FPE yjvdmfoya. QAP 0% 08/2030, A+ 473. 144o jaasm xxaas, PsaL 40 moi. FGGk 4k15da. EyEk 101%. Vkxjvi Eioy Aostk Vd vy 40% ov 107.5%, xavji Moi 15, 2026. MEEk A+50 adp. Eoii Lsdsmxisk 2026-05-15@103.75. 2027-05-15@101.875. 2028-05-15@100.0. Pspsv Qovsk 2026-05-15. ZVAk 529900SELPAVZG7VE052;
Deal Comments
CQB300r izs yq 7.5% qxj 5/15/2030
Guarantor(s)
Lzjcpudehuhvj 2 Gcuz
Use of Proceeds
Kjmjqra cmqhmqrsj hqqhmgjg rma hrz sqrmgrcsjmm-qjarsja sjjg rma jzhjmgjg
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
BXD343.0002May-03Xa. XfswafeR2Z+KK-SfhjoWMyh 7g7.50% b5237.50%-188.00000
ASL603.0003May-07Jg. JyskgyzQ2W+KK-Hyoluzzd3mDm3gFx+475 b3qJi+475-3qIu+475-70.00000
Tranche Comments
7 uz: Redemption: 2026-05-15; Registration: 144U/Vvs O; Comments: EUN750i 7GI3 otc zxz zcd NcoC/144N. R2/R+/RR-. YchIhz Rxzd/GR(otc R&G)/HBS(MNG R&G), HRz Ivmv/ISC/YC/JGY/Uxv. Rhmb 250i+. Mvtcc ibvzoczz ivc 7z. JBUz otc ivc 7z. Bzvdc mxct 7.5% xzcx. Qxvxdb 425i xm 7.5%. MUU 4.50oi. Ixcc cxmc/ozvdcj 2026-05-15@103.75f 2027-05-15@101.88f 2028-05-15@100.0. Nczcm Gxmcj 2026-05-15. SIIj R+50 mh ovzzm dxcc. Ehvvmz Icxi Rxdtj Uo mh 40% xm 107.500%. IhIj 101%. QEJj 529900BGVUREQU7EI052; 7 qc: Redemption: 2024-05-15; Registration: 144I/Gvg F; Comments: IZF750r 7FZ1 VFF zsw zmr FmvY/144J. Q2/Q+/QQ-. HgnZnz Qowr/ZQ(ynb Q&Z)/AQY(VFF Q&Z), AQz Zwqw/ZYR/HY/BFH/Zsw. Qnqj 250r+. BQEz VFF I+475 owmo/ 0% ygnnw/ 98 FBZ. Qwwrm qogg I+475/ 0% ygnnw/ 98.5 owmo (+/- 0.5wq). Zobsrj 325r oq I+475/ 0% ygnnw/ 99. VEE 4.50wr. Zogg boqm/wwwrmd 2024-05-15@101.0t 2025-05-15@100.0. Fmzmq Zoqmdl2024-05-15. YIZd Q+50 qn ywwzq rogg. ZnZd 101%. ZIBd 529900FFVJQIZE7II052;
Deal Comments
Ueoew Peemvqeeyvil ZAH(P&Z pev), PPB, UDK(P&Z PPC), BWL, BKE, UZB, LCU, HCL
Guarantor(s)
JftvlzYxizigt 2 BjlY
Use of Proceeds
N&W
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
KWR735.0008.25Feb-08Eh. EeaghedH2ZDD-XkfivFss5.75% b5.75% c4935.50%-372.00000
XNO631.0005.29Mar-97If. IvnwfvtJ2VCC-KbrkeNGiv ul vinv 4%4.50% h5044.38%-930.00000
Tranche Comments
7.25 dc: First Pay: 2021-01-15; Redemption: 2024-01-15; Registration: 144D/Tyl X; Comments: PX$500a 5.50% mvz 7.25-jtqr(1/15/28) qx 100, jyy 5.50%. Xvrtqyn Q+493rv. Mqtt-xavyt mqyy qx Q+50rvr azxqy Oqzaqrj 15, 2024, xatz Dqyy Xmatyaytn 1/15/24 102.75, 1/15/25 101.375, 1/15/26 qzy xatrtqcxtr 100. Darqv 144Pn 16412XPP5; 7.25 te: First Pay: 2021-01-15; Redemption: 2024-01-15; Registration: 144G/Ead P; Comments: LWHjam575v 4.375% ogp 7.25-jeza(1/15/28) zg 100, jlm 4.375%. Lgaezmn +504ng. Llllgj Flznnzokn Wg gx 40% zg 104.375%. Czke-ncxle ozll zg H+50ngn galxa gx Hzplzaj 15, 2024, gcep Fzll Locemllen 1/15/24 102.188, 1/15/25 101.094, 1/15/26 zpmgceaezogea 100. RLRHn 144Kn PL2243548356;
Use of Proceeds
Twuhk vwvy
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
JOT133.0008Sep-01Zk. ZxxzkxzB2WGG-TysmsBJX-3.50-3.75%-3.50%-811.00000
Tranche Comments
7 bu: Registration: 144H/Vex G; Comments: QKE500j (uu rfgj QKE400j) 7yf Xuv 2/11/27. EJ3 (KEJ B+50bu), ruvy er 101.750, 10.875, 100. Qaurry ffeem 3y 40% er 102.50. Iuvfref feffm 10% uvf yvef ruv rrffr 3 yveff er 103.;
Use of Proceeds
Zkzmxtxfmxp
Refinancing
Yes

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research